Co-Authors
This is a "connection" page, showing publications co-authored by LEI HUO and MING ZHAO.
Connection Strength
0.425
-
Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma. Hum Pathol. 2021 02; 108:42-50.
Score: 0.189
-
Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res. 2020 06 23; 22(1):69.
Score: 0.184
-
Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall. Hum Pathol. 2022 07; 125:35-47.
Score: 0.052